伝統医薬データベース　

サイト内検索結果「」

全16,951件中、3,181件～3,200件を表示しています。
[1] ・・・ [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] ・・・ [848]

Hypaconitine ヒト Hypaconitine,Benzoylhypaconine 18778973, 21550385, 20846913, 19283786 1) Fan Zhanga, Ming-hai Tanga, Li-juan Chena, Rui Li, Xian-huoWang, Jun-guo Duan, Xia Zhao, Yu-quanWei, Simultane

6362. [生薬成分の代謝] 代謝マップ『6-Gingerol』

6-Gingerol ヒト、ラット [6]-Gingerol,,,,,,[6]-Shogaol(M1), Oral administration,Oral administration,Oral administration,Oral administration,Oral administration,Oral administration 21638149, 1337351, 18708382

6363. [生薬成分の代謝] 代謝パラメータ『Oral administration』

Oral administration 50 mg/kg 0.31 ± 0.027 h 1.91 ± 0.535 h 0.96 ± 0.03 h 28.5 ± 3.48 ng/ml 111.6 ± 5.905 ng∙h∙ml^-1 0-limit 3.19 ± 0.483 h Ganoderiol F 代謝パラメータ

6364. [生薬成分の代謝] 代謝マップ『Scoparone (6,7-dimethylesculetin)』

Scoparone (6,7-dimethylesculetin) ラット Scoparone Oral administration 18264991 1) Haitao Lv, Hui Sun, Xijun Wang, Wenjun Sun, Guozheng Jiao, Dixin Zhou, Li Zhao, Hongxin Cao, Guangmei Zhang, Simultaneou

6365. [生薬成分の代謝] 代謝マップ『Verproside』

Verproside ラット (Sprague-Dawley rat) Verproside Intravenous administration,Intravenous administration,Intravenous administration,Intravenous administration,Intravenous administration,Intravenous admini

6366. [生薬成分の代謝] 代謝パラメータ『Intravenous administration』

Intravenous administration 20 mg/kg kel 0.193 ± 0.014 (h ± 1) serum ke 0.015 ± 0.001 (h ± 1)urine 3.678 ± 0.250 (h) serum 47.385 ± 3.646 (h) urine Vss 4.879 ± 0.507 l/kg CLrenal 0.070 ± 0.019

6367. [生薬成分の代謝] 代謝パラメータ『Oral administration』

Oral administration 50 mg/kg 360 min 49.6 ± 5.15 pmol/ml 9936 pmol・min/ml 0-10 h Saikosaponin 代謝パラメータ

6368. [生薬成分の代謝] 代謝マップ『Cycloastragenol』

Cycloastragenol Caco-2 細胞、ラット及びヒト肝ミクロソーム Cycloastragenol,AstragalosideⅣ 20877137, 18346946, 17702194 1) Zhu J, Lee S, Ho MK, Hu Y, Pang H, Ip FC, Chin AC, Harley CB, Ip NY, and Wong YH.: In vitro int

6369. [生薬成分の代謝] 代謝マップ『Isovanilloylcatalpol』

Isovanilloylcatalpol ラット (Sprague-Dawley rat) Isovanilloyl catalpol Intravenous administration,Intravenous administration,Intravenous administration 19407974, 19353737 1) Eun Jeong Park, Hyun Sook Lee

6370. [生薬成分の代謝] 代謝マップ『Resibufogenin』

Resibufogenin 微生物（Nocardia sp. NRRL 5646 ラット Resibufogenin,3-Acetyl resibufogenin,3-Acetyl-15β-hydroxybufotalin Intragastric administration 17911017, 17928276 1) Jian Zhang, Yang Sun, Ji-Hua Liu, Bo-Y

6371. [生薬成分の代謝] 代謝マップ『6-Shogaol』

6-Shogaol ヒト、ラット 8-Gingerol Oral administration,Oral administration,Oral administration 21638149, 21337351, 18708382 1) Yanke Yu, Suzanna Zick, Xiaoqin Li, Peng Zou, Benjamin Wright, and Duxin Sun: Ex

6372. [生薬成分の代謝] 代謝パラメータ『Oral administration』

Oral administration 50 mg/kg 30 min 113 ± 6.07 pmol/ml 34308 pmol・min/ml 0-10 h Saikosaponin 代謝パラメータ

6373. [生薬成分の代謝] 代謝マップ『Emodin』

Emodin ラット Emodin 18264991 1) Haitao Lv, Hui Sun, Xijun Wang, Wenjun Sun, Guozheng Jiao, Dixin Zhou, Li Zhao, Hongxin Cao, Guangmei Zhang, Simultaneous determination by UPLC–ESI-MS of scoparone, capi

6374. [生薬成分の代謝] 代謝物『2-oxo-4-(1-oxobut-3-en-2-yl)-5,6-dihydro-2H-pyran-3-carbaldehyde』

2-oxo-4-(1-oxobut-3-en-2-yl)-5,6-dihydro-2H-pyran-3-carbaldehyde 2-oxo-4-(1-oxobut-3-en-2-yl)-5,6-dihydro-2H-pyran-3-carbaldehyde C10H10O4 194.187 194.0579 195.0657 193.0501 Swertiamarin 代謝物

6375. [生薬成分の代謝] 代謝物『(2R,3R)-2-(3',4'-Dihydroxybenzyl)-3-(3",4"-dimethoxybenzyl) butyrolactone』

(3R,4R)-3-(3,4-dihydroxybenzyl)-4-(3,4-dimethoxybenzyl)dihydrofuran-2(3H)-one (2R,3R)-2-(3',4'-Dihydroxybenzyl)-3-(3",4"-dimethoxybenzyl) butyrolactone C20H22O6 358.391 358.1416 359.1495 357.1338 Ar

6376. [生薬成分の代謝] 代謝マップ『Catalposide』

Catalposide ラット (Sprague-Dawley rat) Catalposide 19353737 1) Eun Jeong Park, Sei-Ryang Oh, Hyeong-Kyu Lee and Hye Suk Lee, Liquid chromatography–mass spectrometry for the simultaneous determination o

6377. [生薬成分の代謝] 代謝物『(+)-Lariciresinol』

(S)-2-methoxy-4-(tetrahydrofuran-2-yl)phenol compound with 4-(4-hydroxybutyl)-2-methoxyphenol (1:1) (+)-Lariciresinol 27003-73-2 C22H30O6 390.477 390.2042 391.2121 389.1964 Pinoresinol diglucoside 代謝

6378. [生薬成分の代謝] 代謝物『4-((2S,3S)-4-hydroxy-3-(4-hydroxy-3-methoxybenzyl)-2-(hydroxymethyl)butyl)benzene-1,2-diol』

4-((2S,3S)-4-hydroxy-3-(4-hydroxy-3-methoxybenzyl)-2-(hydroxymethyl)butyl)benzene-1,2-diol 4-((2S,3S)-4-hydroxy-3-(4-hydroxy-3-methoxybenzyl)-2-(hydroxymethyl)butyl)benzene-1,2-diol C19H24O6 348.396

6379. [生薬成分の代謝] 代謝物『(3S,4S)-3-(3,4-Dihydroxybenzyl)-3-hydroxy-4-(4-hydroxy-3-methoxybenzyl)-dihydrofuran-2(3H)-one』

(3S,4S)-3-(3,4-dihydroxybenzyl)-3-hydroxy-4-(3-hydroxy-4-methoxybenzyl)dihydrofuran-2(3H)-one (3S,4S)-3-(3,4-Dihydroxybenzyl)-3-hydroxy-4-(4-hydroxy-3-methoxybenzyl)-dihydrofuran-2(3H)-one C19H20O7 3

6380. [生薬成分の代謝] 代謝物『Unable to generate chemical name』

Unable to generate chemical name Unable to generate chemical name C16H10NO5 R 296.259 296.0559 297.0637 295.0481 Aristlochic acid 代謝物

[1] ・・・ [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] ・・・ [848]
全16,951件中、3,181件～3,200件を表示しています。

ページの上へ戻る

TOPICS

生薬

漢方

試験薬物

遺伝子解析情報

化学分析情報

活性試験情報

生薬成分の代謝情報

探索研究